GenQA at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

GenQA brings 1 presentation to ASHG 2026 in Montréal, and exhibits at Booth 700. Its ASHG 2026 program centres on rare disease, cancer and clinical genetics. GenQA presents a year review of GENie assessments for BRCA1, BRCA2 and other HRR genes.

Organization

ASHG 2026 Attendance

GenQA

Hawick, UK

1 Genetic Technologist

genqa.org|LinkedIn

Private company

GenQA provides external quality assessments and proficiency testing for genomic laboratories, clinical genetics centres, and individual clinicians. It also sells online competency and training tools.

Two GenQA staff members contributed to new ACGS guidance on structural-variant interpretation, a thought-leadership contribution rather than a product launch.

›

Two GenQA staff members contributed to new ACGS guidance on structural-variant interpretation, a thought-leadership contribution rather than a product launch.

2026-06 · source

The UK NEQAS consortium it belongs to won the contract to run all National Genomic Test Directory quality assessments through 2028.

2026-05 · source

Launched a new GENie module for somatic variant classification, adding tumor and blood-cancer proficiency testing to its program.

2026-03 · source

Source: company newsroom

Booth

Exhibiting at Booth 700

Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Poster

Thu Oct 22
4:15 pm

Part of Genetic Counseling, ELSI, and Education Poster Thursday Session